Manchester united are ready to welcome second signing of the transfer window after finalising Tyrell Malacia deal on weekend,Red devils have come to a full agreement with Christian Erisken and is set be at Old Trafford come next season.
Former Tottenham midfielder will sign three years deal and his medical test is scheduled to take place within the course of the week,arrival of Christian to Manchester united, is added advantage to the midfield.
Portuguese international Joao Moutinho,is set to remain at Molineux stadium come next season after signing a new deal with the club till 2023,deal is done and sealed.Newly promoted Nottingham forest is very active on the ongoing transfer window having already signed two player as they are looking to strengthen their squad before season starts, Moussa Niakhate is another new signing for Nottingham from Mainz at release fee of 10m plus 5m add ons,his medical test is set to be this week.
Content created and supplied by: Supersport9 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More